Company / Operating Margin
GeneDx Holdings Corp. Operating Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-3.1%
FY2025
5-year range
-284.5% / -3.1%
FY2021-FY2025
Trend
+59.7%
vs FY2024
Sector context
#101 of 143
Health Care
What the data says
At -3.1%, GeneDx Holdings Corp.'s operating margin ranks #101 of 143 in the Health Care sector. Operating Margin has increased for 3 consecutive years, from -284.5% in FY2022 to -3.1% in FY2025.
Based on SEC 10-K filings.
-3.1% in FY2025 with a 3-year CAGR of +281.4%.
Improved from -89.1% to -3.1% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +281.4pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#101 of 143 in Health CareTop 71% of 143This company -3.1% Sector average -295.2%
▼
+99.0% above sector average
Key checks
Key Insights
- GeneDx Holdings Corp.'s operating margin has grown for 3 consecutive years.
- In FY2025, operating margin increased 59.7% year-over-year.
- Currently 292.2pp above the Health Care sector average.
- Lowest operating margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3.1% | +59.7% |
| FY2024 | -7.6% | +91.5% |
| FY2023 | -89.1% | +68.7% |
| FY2022 | -284.5% | -35.3% |
| FY2021 | -210.3% | - |
| FY2020 | - | - |
| FY2019 | -15.5% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026